Regulations finalized by the Environmental Protection Agency in 2024 could cut emissions from the power sector by 51% over 2022 levels, compared to only 26% without the rules, according to a new ...
Tirzepatide and semaglutide offer long-term health benefits, but would require discounts to reach $100,000/QALY threshold ...
Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.
A data analysis published in a scientific journal indicates that differences with placebo are marginal for most treatments ...
While climate adaptation decisions are not simple, reinforcement learning is a highly efficient system for incorporating ...
By implementing strategies such as fine-tuning smaller models and real-time AI cost monitoring, financial institutions can ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback